Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 09, 2024 16:00 ET
|
Mural Oncology, Inc.
Mural Oncology, a clinical-stage immuno-oncology company, shared pre-clinical data from its Interleukin-18 (IL-18) and IL-12 programs at AACR today.
Aegion Announces Acquisition of Toncco
March 27, 2024 11:00 ET
|
Aegion Corp
Aegion Corporation today announced the acquisition of Toncco, an underground utilities company based in Ogden, Utah.
Inter&Co Inc. Reports Record Profits, with R$352 Million in Net Income in 2023
February 07, 2024 16:47 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the premier Financial Super App that provides financial and digital commerce services to more...
Inter&Co Secures Long-Term Naming Rights for Orlando’s Soccer-Specific Stadium
January 18, 2024 11:10 ET
|
Inter&Co, Inc
Financial Super App secures long-term naming rights; Home of Orlando City SC and Orlando Pride to be renamed Inter&Co StadiumFirst-of-its-kind international partnership will bring new investment...
Inter&Co Announces Commencement of Follow-on Public Offering of its Class A Common Shares
January 16, 2024 17:44 ET
|
Inter&Co, Inc
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- INTER & CO, INC. (NASDAQ: INTR; B3: INBR32) (“Inter&Co” or the “Company”) announced, on the date hereof, the commencement of a follow-on public...
Boehringer expands production site in Greece for new medicine
January 11, 2024 10:15 ET
|
Boehringer Ingelheim
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the...
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
January 08, 2024 07:00 ET
|
Mural Oncology, Inc.
Strategic changes to ARTISTRY-6 and ARTISTRY-7, both potentially registrational trials of nemvaleukin, are intended to result in more clinically meaningful dataMural intends to nominate development...
Inter&Co presents new brand and consolidates position as financial Super App
December 20, 2023 08:10 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inter&Co has a new brand to reflect the company's evolution. Three years after its last rebranding, the institution is unveiling a new...
EVerZom : Ambition thérapeutique dans les biothérapies à base d’exosomes
December 13, 2023 05:07 ET
|
Everzom
EVerZom : Ambition thérapeutique dans les biothérapies à base d’exosomes Lauréat de l’EIC Accelerator pour sa plateforme d’innovation technologique, EVerZom dévoile son pipeline propriétaire de...
EVerZom: Therapeutic Ambition in Exosome Biotherapies
December 13, 2023 05:07 ET
|
Everzom
EVerZom: Therapeutic Ambition in Exosome Biotherapies EVerZom, winner of the EIC Accelerator for its breakthrough technology platform, presents its proprietary pipeline of exosome-based...